With Synapse Platform, healthcare professionals can analyse whether one or more treatments present drug-related risks based on the patient's clinical characteristics: contraindications, drug interactions, adverse drug effects, and STOPP criteria.
Improve coordinated care and patient safety
With Synapse Platform, HCPs can rely on a robust medicines reconciliation technology to prevent medication errors and improve patient safety. Our goal is to reduce iatrogenic risks from hospital admission to discharge.
Improving clinical trial safety with Synapse Platform’s proprietary Medication Intelligence technology
Synapse Medicine's team is involved in ambitious clinical research projects related to proper drug use. These innovative collaborations allow us to develop our position as international leaders in the use of drug data in hospitals.
The PRoSIT project
A unique consortium of France’s top university hospitals, Inserm, and Synapse Medicine conducted a scientific study on drug interactions as part of the French Ministry for Health's 2019 French Research Program on Performance of Healthcare Systems (PREPS).
Director General of Bordeaux University Hospital
Bordeaux University Hospital is proud to collaborate with Synapse Medicine for two reasons. The first is that it provides a concrete and innovative solution that makes care safer. The second is that Synapse is a spin-off from Bordeaux University Hospital, which has now become a reference in its category.
Pharmacologist from Bordeaux University Hospital managing the PRoSIT project
Winning the funding for the PRoSIT project was the culmination of many months of work involving teams from very different professional backgrounds. This collaboration with Synapse Medicine is particularly interesting for us because it uses their experience in machine learning and applies it to health data.
Our Co-founder and Medical Director’s scientific publications
Louis Létinier MD-PhD, one of the Co-founders and the Medical Director of Synapse Medicine, worked as a hospital pharmacologist at Bordeaux University Hospital.
His pharmacological expertise shines through the Synapse Platform and his numerous scientific publications:
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France…
Létinier L, Cossin S, Mansiaux Y, Arnaud M, Salvo F, Bezin J, Thiessard F, Pariente A.
Impact of cancer diagnosis on persistence of oral antidiabetic drugs.
Létinier L, Mansiaux Y, Pariente A, Fourrier-Réglat A.
Psychoactive substances: Pharmacokinetic clues for harm…
Daveluy A, Géniaux H, Baumevieille M, Letinier L, Matta MN, Lazès-Charmetant A, Haramburu F, Guéroult P
Pharmacological treatments of cardiovascular diseases: Evidence…
Salvo F, Bezin J, Bosco-Levy P, Letinier L, Blin P, Pariente A, et al.
PRognostic factor of Early Death In phase II Trials or the end of …
Grellety T, Cousin S, Letinier L, Bosco-Lévy P, Hoppe S, Joly D, et al.